Loading market data...
markets

Ozempic face? Botox boom boosted by 'sagging face' trend, Swiss firm says

CNBC
Read Full Article at CNBC
Share:PostShare
Ad Slot — In-Article (728x90)

The aestetics company hope increased GLP-1 use will fuel demand for treatments addressing facial volume loss, sometimes dubbed "Ozempic face.

This is a summary. For the full story, read the original article at CNBC.

Original source: CNBC

Ad Slot — Below Article (300x250)